Clinical Trial

SGLT2 Adjunct in T1D

Completed Phase 2/3
View on ClinicalTrials.gov →
Summary
Effect of Sodium-Glucose Cotransporter (SGLT) 2 Inhibitors on Diabetic Nephropathy Progression in Adolescents with Type 1 Diabetes Mellitus
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-09.
Trial Details
NCT Number NCT07591077
Lead Sponsor Ain Shams University
Conditions Type 1 Diabetes, Nephropathy, Diabetic
Enrollment 86 participants
Start Date 2024-11-20
Primary Completion 2025-11-20 (estimated)
Study Completion 2026-02-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-18